Background: The United States currently faces a public health crisis with regarding to antibiotic-resistant bacteria, and new urinary tract infection (UTI) diagnostics are needed. Women with recurrent UTI (rUTI) and complicated UTI (cUTI) are at particular risk given their complexity and the paucity of adequate testing modalities. The standard urine culture (SUC) is the cornerstone for diagnosis, but it has many shortcomings. These pitfalls lead to dissatisfaction and frustration among women afflicted with rUTI and cUTI, as well as overuse of antibiotics. One innovation is PCR UTI testing, which has been shown to outperform SUC among symptomatic women.
Aims: This article discusses UTI PCR testing, as well as a possible role in clinical practice.
Materials and methods: Published literature was reviewed and summarized.
Results: Management of rUTI and cUTI is complex, and providers should have all diagnostics available to facilitate providing optimal care. Urine PCR testing faces reimbursement issues despite fulfilling clinical indication parameters as described by insurance companies.
Discussion: The role of UTI PCR testing remains unclear. Reimbursement issues have led to underuse and limited real-world outcomes reinforcing benefit.
Conclusion: This study proposes an algorithm for PCR testing among women with rUTI and cUTI.
Keywords: UTI PCR testing; advanced UTI testing; antibiotic resistance; complicated UTI; recurrent UTI.
© 2023 Wiley Periodicals LLC.